Dr. Firoozeh Parsa Nezhad, MD

Dr. Parsa Nezhad practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Parsa Nezhad's NPI, 1104969229, was assigned on February 15, 2007. Dr. Parsa Nezhad holds California license A90823.

Dr. Parsa Nezhad's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Parsa Nezhad's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Parsa Nezhad is also affiliated with Laguna Honda Hospital & Rehabilitation Center. The medical group on file is San Francisco Public Health Laboratory. Dmand AI also links Dr. Parsa Nezhad to 1 more skilled nursing facility, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parsa Nezhad practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Parsa Nezhad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Parsa Nezhad is licensed in California.

CMS data shows 186 Medicare services from Dr. Parsa Nezhad across 2 procedure codes in 2024, for 42 Medicare patients. Medicare paid $10,816 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Parsa Nezhad in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 100% are also on Medicaid. Their average risk score is 3.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parsa Nezhad's median patient age at 67, with 35% women.

In 2024, Dr. Parsa Nezhad wrote 4,117 Medicare Part D claims for 35 patients. 88% of them were for generic drugs. CMS names the drug for 3,806 of them, across 64 drugs with 11 or more claims each, at $150,719 in total drug cost. In 2023, CMS named 3,159 claims across 70 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Parsa Nezhad for performance year 2024, reported as part of a group. Dr. Parsa Nezhad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.